BridgeMD
New treatment option for Meningioma
Official title Embolization for Meningioma
ClinicalTrials.gov ID: NCT05416567
What this study is testing
- What it's testing
- The natural course for meningioma suggests that a majority will grow over time. Treatment is usually indicated in growing or symptomatic meningiomas.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Radiological diagnose of typical intracranial meningioma (homogenous contrast enhancement or dural attachment)
- Indication for treatment due to growth, symptoms or both
- Tumor location suggestive of vascular supply via middle meningeal artery branches
- Age 18 years or older
- Karnofsky performance status of 90 or better (able to carry on normal activity and work)
You likely can't join if
- Informed consent not possible (e.g. language barriers, aphasia, cognitive impaired)
- Previously treated for meningioma
- Intraosseous growth
- Tumor related brain edema
- Neurofibromatosis type 2
- Systemic cancer
See the full eligibility criteria
- Radiological diagnose of typical intracranial meningioma (homogenous contrast enhancement or dural attachment)
- Indication for treatment due to growth, symptoms or both
- Tumor location suggestive of vascular supply via middle meningeal artery branches
- Age 18 years or older
- Karnofsky performance status of 90 or better (able to carry on normal activity and work)
- Informed consent not possible (e.g. language barriers, aphasia, cognitive impaired)
- Previously treated for meningioma
- Intraosseous growth
- Tumor related brain edema
- Neurofibromatosis type 2
- Systemic cancer
- Epilepsy
- Progressive neurodegenerative disorder (eg. MS, Parkinsons disease)
- History of psychiatric disorder
- Unfit for participation for any other reason judged by the physician including patients
- Contraindications to MRI
- Allergic to contrast agents
- Relative contraindications to endovascular treatment judged from CT angiography (tortoise carotid arteries, carotid stenosis, calcified aortic arch, anatomical vascular variants/anomalies suggesting increased risk with...
- DSA (Digital subtraction angiography) from carotid artery suggesting that significant vascular supply is from other vessels than the MMA.
The study team makes the final eligibility decision.
Where it's taking place
- Trondheim, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Trondheim, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.